C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/271, 260/299
C07D 471/08 (2006.01) C07D 223/04 (2006.01) C07D 487/08 (2006.01)
Patent
CA 1223873
ABSTRACT A compound of formula (I), or a pharmaceutically acceptable salt, or N-oxide thereof, or a solvate of any of the foregoing: Image (I) wherein p is 0 to 2; q is 0 to 3; j is 0 to 4; one of R5 and R6 is hydrogen, C1-6 alkyl, phenyl or phenyl-C1-3 alkyl, which phenyl moietes may be substituted by C1-6 alkyl, C1-6 alkoxy, CF3 or halogen; and the other of R5 and R6 is hydrogen or C1-6 alkyl; and - 2 - A is of formula (II): Image (II) wherein R2, R3 and R4 are each independently selected from hydrogen, halogen, CF3, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-7 acyl, C1-7 carboxylic acylamino, C1-6 alkylsulphonylamino, N-(C1-6 alkylsulphonyl)-N- C1-4 alkylamino, C1-6 alkylsulphonyl, C1-6 alkylsulphinyl, hydroxy, nitro or amino, aminocarbonyl, aminosulphonyl, aminosulphonylamino or N-(aminosulphonyl)-C1-4 alkylamino optionally N-substituted by one or two groups selected from C1-6 alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl C1-4 alkyl, phenyl or phenyl C1-4 alkyl groups or optionally N-disubstituted by C4-5 polymethylene; or any two together are C1-2 alkylenedioxy; j is 0 to 4; and i) R1 is independently any one of the values for R2, R3 or R4 except hydrogen or together with R2 is C1-2 alkylenedioxy, C1-2 oxyalkylenethio, C2-3 alkyleneoxy or N-(C1-2 oxyalkylene)-N-C1-6 alkylamino; and one of X is CO and the other is NH; or ii) X is CO and Y is NR16 where R1 and R16 together are C1-2 alkylene; or - 3 - ii) A is of formula (III): Image (III) wherein: R2, R3 and R4 are as defined in formula (II); G is -N= or -NR13 where R13 is hydrogen or C1-4 alkyl; L is >C<; E, J and X are each independently -CHR14, -CR14=, -N= or -NR15 where R14 is hydrogen, C1-4 alkyl or C1-4 alkylthio, and R15 is hydrogen or C1-4 alkyl, or one of E, J and Z is C:B where B is O or S and the other two are each independently -CR14=, -N= or -NR15 where R14 and R15 are as defined; or E is a bond, one of J and Z is -CHR14=, -N= or -NH15 as defined and the other is -CHR14=, -N=, O or S; or iii) A is of formula (IV): Image (IV) - 4 - wherein: R1, R3 and R4 are as defined in formula (II), except that none is combined with any other variable to form a divalent group; and the nitrogen atom depicted in formula (I) is separated from the nearest nitrogen atom in the moiety A by at least 2 carbon atoms; a process therefor and compositions thereof.
425690
Alizyme Therapeutics Limited
Borden Ladner Gervais Llp
LandOfFree
Pharmaceutically active compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically active compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1335859